Community outbreak of
hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995.
Complement functional tests for monitoring eculizumab treatment in patients with atypical
hemolytic uremic syndrome.
She has a history of
Hemolytic Uremic Syndrome with chronic renal insufficiency in young childhood.
This report provides comprehensive information on the therapeutic development for Atypical
Hemolytic Uremic Syndrome (Nondiarrhea- Associated
Hemolytic Uremic Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized with the triad of microangiopathy hemolytic anemia, thrombocytopenia and acute renal damage.
The association between
hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
Shiga toxin activates complement and binds factor H: evidence for an active role of complement in
hemolytic uremic syndrome.
Hemolytic uremic syndrome is a complex disorder, affecting both children and adults.
Non-shiga toxin-associated
hemolytic uremic syndrome.
SAN FRANCISCO -- Treatment of Shiga toxin-producing Escherichia coli 0157 infection with beta-lactams is associated with increased risk for post-diarrheal
hemolytic uremic syndrome in both children and adults, according to findings from a population-based study.
Hemolytic uremic syndrome (HUS) is defined by a triad of microangiopathic hemolytic anemia (characterized by schistocytes and helmet cells, as shown in Fig.
For Embase/Medline and Scopus, we used a combined search of the following concepts and their Emtree synonyms: Shiga Toxins, Shigella, and
Hemolytic Uremic Syndrome.
